Does TOFACITINIB Cause Ankylosing spondylitis? 158 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 158 reports of Ankylosing spondylitis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
158
Reports of Ankylosing spondylitis with TOFACITINIB
0.1%
of all TOFACITINIB reports
0
Deaths
29
Hospitalizations
How Dangerous Is Ankylosing spondylitis From TOFACITINIB?
Of the 158 reports, 29 (18.4%) required hospitalization.
Is Ankylosing spondylitis Listed in the Official Label?
Yes, Ankylosing spondylitis is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Ankylosing spondylitis?
CERTOLIZUMAB PEGOL (2,580)
ADALIMUMAB (2,378)
SECUKINUMAB (1,942)
ETANERCEPT (1,456)
METHOTREXATE (1,067)
DICLOFENAC (874)
INFLIXIMAB (789)
GOLIMUMAB (643)
LEFLUNOMIDE (413)
CELECOXIB (329)
Which TOFACITINIB Alternatives Have Lower Ankylosing spondylitis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN